NHS SBS launches £900m AI procurement framework

TL;DR:

• NHS Shared Business Services (NHS SBS) has launched a £900m “Healthcare AI Solutions” framework, running from 12 May 2027 to 11 May 2035.
• The framework covers diagnostics, predictive analytics, robotics, operational efficiency and advisory services across eight lots — and is explicitly open to SMEs as well as larger suppliers.
• Critics including GP and clinical informatician Marcus Baw have called the framework’s value disproportionate, warning of “free money for mega corporations” at a time of squeezed NHS finances.

NHS Shared Business Services has published a £900m framework agreement designed to be the national procurement route for AI across the NHS and wider UK public sector. The tender notice — published on 11 May 2026 — sets a long contract window from May 2027 through May 2035, with submissions due by 23 June 2026 and contract awards expected in March 2027.

The framework is structured across eight lots: radiology and diagnostic imaging, pathology and preventative healthcare, virtual and robotic health, predictive analytics, research and innovation, operational efficiency, advisory services, and an “integrated combined solutions” lot reserved for suppliers winning two or more of the other lots.

A strategic procurement vehicle, with critics

NHS SBS framed the framework as strategically aligned with the Darzi report and the ambitions of the NHS Long Term Plan, with stated priorities of tackling misdiagnosis, reducing waiting times for test results and treatment, and minimising administrative inefficiencies. Paddy Howlin, NHS SBS procurement solutions director, described the framework as the first to offer this breadth of coverage and said it should give NHS organisations a swift and compliant route to “life-saving technology.”

Approved buyers can award contracts either through mini-competition or direct award, with the SME-friendly framing intended to keep specialist clinical-AI vendors in the running alongside the larger consultancies and integrators.

Not all clinicians are persuaded. Marcus Baw, a GP, clinical safety officer and software engineer, told Digital Health News that the framework amounts to “free money for mega corporations at a time when medicine is rapidly becoming an economically unviable occupation,” and described NHS England’s spending as “out of control.”

Looking forward

The framework will shape UK clinical-AI procurement for the better part of a decade. Three questions will define whether it delivers value or simply concentrates spend. First, whether the SME-friendly framing translates into meaningful contract awards or whether familiar large integrators capture the bulk of Lot 8. Second, how procurement decisions handle clinical safety and post-deployment evaluation — a domain where the NHS is already grappling with patchy assurance. Third, whether £900m of AI procurement displaces or duplicates spend on existing NHS digital programmes. Combined with the recent HMRC-Quantexa £175m AI deal and DWP-Wordnerds £100k sentiment-analysis pilot reported earlier this week, the UK public sector is now committing serious procurement capacity to AI vendors — making evidence on outcomes, not just shortlists, the metric that matters.